Generic Name and Formulations:
Epinephrine (as HCl) 1mg/mL; soln for IM or SC inj; contains sulfites.
Par Pharmaceutical, Inc.
Indications for ADRENALIN:
Emergency treatment of allergic reactions (Type I), including anaphylaxis. Bronchospasm. Urticaria. Angioedema. Serum sickness.
Adults and Children:
Do not dilute. Inject into the anterolateral aspect of the thigh. ≥30kg: 0.3–0.5mg SC or IM; max: 0.5mg per inj. <30kg: 0.01mg/kg SC or IM; max: 0.3mg per inj. Both: may repeat every 5–10 mins as necessary; rotate inj sites. Monitor clinically for reaction severity and cardiac effects.
Avoid injecting into the buttocks, digits, hands, or feet. Cardio or cerebrovascular disease. Hypertension. Diabetes. Hyperthyroidism. Parkinson's disease, Pheochromocytoma. Elderly. Pregnancy (Cat.C). Labor & delivery. Nursing mothers.
Additive effects with concomitant other sympathomimetic agents. Caution with cardiac glycosides, digitalis, diuretics, quinidine, and other arrhythmia-producing agents; monitor. Pressor effects may be potentiated by tricyclic antidepressants, MAOIs, antihistamines, levothyroxine. May be antagonized by α-blockers (eg, phentolamine), β-blockers (eg, propranolol), ergots. Caution with halogenated hydrocarbon general anesthetics (eg, halothane). Do not use to counteract effects of phenothiazines.
Anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea, vomiting, headache, respiratory difficulties, angina, arrhythmias, ventricular fibrillation (may be fatal), rapid rises in BP, cerebral hemorrhage; rare: serious infections at the inj site.
Single-dose vials (1mL)—25; Multi-dose vials (30mL)—1, 10
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of ADHD Relatively Stable Over Time Despite Increase in Diagnoses
- Prevalence of Major Depressive Disorder Remains High In US Population
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Evidence of Methylphenidate Abuse: Characterizing Patterns of Use in Pediatric and Adult Populations
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- Most Patients Comfortable With Clinicians Asking About Sexual Orientation
- Peer-to-Peer Depression Awareness Program May Be Beneficial
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders